As of Sep 04
| +0.12 / +0.09%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 185.00, with a high estimate of 185.00 and a low estimate of 185.00. The median estimate represents a +38.81% increase from the last price of 133.28.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.